MWA: Clinical Trials

3 trials of MWA, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 active not recruiting, 1 not yet recruiting, 1 recruiting. 3 Phase 2, 2 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 23Active not recruiting 1, Not yet recruiting 1, Recruiting 1
Phase 32Not yet recruiting 1, Recruiting 1

Follow MWA: new trials by email Literature Review of MWA trials Research Report on MWA

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Injection of IP-001 Into Thermally Ablated Hepatic Tumors in Patients With Colorectal Liver Metastases
1.0% IP-001 for Injection, a 10 mg/mL solution of IP-001 in water, 1.0% IP-001 for Injection, a 1 mg/mL solution of IP-001 in water., Microwave (thermal) tumor ablation - Colorectal Cancer (CRC), Colon Cancer Liver Metastases
Phase 2 / Phase 3Not yet recruitingImmunophotonics, Inc.7172026-05-012026-01-07
Microwave Ablation Versus Stereotactic Body Radiotherapy for Colorectal Liver Metastases in Oligometastatic Disease: a Prospective, Randomised, Phase 2 Trial
MWA, SBRT - Colorectal Carcinoma, Liver Metastases
Phase 2Active not recruitingCopenhagen University Hospital, Rigshospitalet1002018-07-252026-03-19
Combination Therapy of Microwave Ablation and Cellular Immunotherapy for Hepatocellular Carcinoma
adoptive immunotherapy, MWA - Hepatocellular Carcinoma
Phase 2 / Phase 3RecruitingChinese PLA General Hospital802009-12-012026-09-17

Conditions studied

Colorectal Neoplasms (2)  ·  Carcinoma, Hepatocellular (1)  ·  Neoplasm Metastasis (1)  ·  Neoplasms (1)  ·  Rectal Neoplasms (1)

Sponsors

Chinese PLA General Hospital (1)  ·  Copenhagen University Hospital, Rigshospitalet (1)  ·  Immunophotonics, Inc. (1)

Countries

China (1)  ·  Denmark (1)

Top investigators

Diane M Beatty, PhD (1)  ·  Ping Liang, Dr. (1)

Results publications

PMID 42829779

NIH funding

2025 (1)